Prescription drug sales rose 5.1% to $300 billion in 2009, according to IMS Health. Growth was driven by increased use of specialty treatments, a relatively easy year in patent expiries and the absence of major safety problems, investigators found. That’s a big improvement over 2008’s 1.8% growth, but it’s still pretty meager compared to the double-digit gains common until 2007.
http://www.imshealth.com/portal/site/imshealth
